On 12 September 2014 RFE advised it is considering either refinancing or asset sales or maybe both to allow it to repay a secured loan which was due at the end of September.
Yesterday the company appears to have advised that asset sales are off the agenda preferring a new loan facility on which to go forward.
RFE is not in default over the loan because the existing loan provider doesn't appear to have raised a default on the company. On the contrary the existing provider of the expired loan facility seems to be working with RFE and a new loan provider to clear the debt.
If I have read the reports correctly then nobody can justify RFE being a 3 cent stock.
With James Packer being associated with a company which is a major holder of RFE shares I cant see the company share price hanging around 3 cents for much longer.
- Forums
- ASX - By Stock
- RFE
- Ann: Re-financing Partner Selected
Ann: Re-financing Partner Selected, page-41
-
- There are more pages in this discussion • 66 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RFE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online